SCHEMBL5363156

SCHEMBL5363156

COc1cc(OC)c(C=C2C(=O)Nc3ccc(S(=O)(=O)Nc4ccc(C(F)(F)F)cc4)cc32)c(OC)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MOGAT2 Q3SYC2 4/20 0.55
MAPK1 P28482 2/20 0.54
MEN1 O00255 1/20 0.54
ALOX15 P16050 1/20 0.54
KMT2A Q03164 1/20 0.54
CSNK1D P48730 3/20 0.53
CSNK1A1 P48729 2/20 0.53
CSNK1E P49674 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
GMNN O75496 1/20 0.53
ALDH1A1 P00352 1/20 0.53
LMNA P02545 1/20 0.53
TP53 P04637 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
CYP2C9 P11712 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
THPO P40225 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364990 0.92 MOGAT2 (0.56) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5363913 0.90 MDM2 (0.59) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5365559 0.90 MOGAT2 (0.56) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5367049 0.89 MEN1 (0.54) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5369913 0.88 MOGAT2 (0.56) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5368257 0.87 MEN1 (0.57) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5364814 0.86 GSK3B (0.57) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5364979 0.86 MEN1 (0.61) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL7137732 0.86 MOGAT2 (0.55) MOGAT2MAPK1MEN1ALOX15KMT2A
SCHEMBL5364674 0.86 MOGAT2 (0.52) MOGAT2MAPK1MEN1ALOX15KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7202265-B2 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. (US) 2007-04-10 US disclosed
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease SUGEN, INC. 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197382-A1 Indolinone combinatorial libraries and related products and methods for the treatment of disease FRK, PTK2, DSTYK MOGAT2 1159/4885MAPK1 424/4885MEN1 3855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.